Global Double Roller Pump Artificial Heart Lung Machine Market Strategic Research Report

Scope of the Report

The global Double Roller Pump Artificial Heart Lung Machine market size is predicted to grow from US$ 109 million in 2025 to US$ 137 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.

Double Roller Pump Artificial Heart Lung Machines are high-performance medical devices widely used in complex extracorporeal circulation surgeries. By employing two roller pumps, these machines independently drive systemic and oxygenator circuits while integrating oxygenators, heat exchangers, monitoring modules, and medical tubing systems to achieve precise blood flow control, oxygenation, and temperature regulation. They are primarily applied in coronary artery bypass grafting, heart valve replacement, heart transplantation, and complex major vascular procedures, fully replacing heart and lung functions during surgery and ensuring stable circulation and adequate tissue oxygen supply. Compared to single-pump systems, double roller pump designs provide more precise hemodynamic control, allowing independent management of systemic and oxygenator circuits, which is especially suitable for prolonged surgeries and high-risk patients, enhancing surgical safety and postoperative recovery. With the growth of minimally invasive surgery, precision perioperative management, and high-complexity cardiac operations, double roller pump machines have become essential core devices in large hospitals and specialized cardiac surgery centers worldwide.In 2025, global Double Roller Pump Heart Lung Machines production reached approximately 397 Units and price is about 281 K USD/Unit.The average gross profit margin of this product is 45%.

The double roller pump artificial heart lung machine market is driven by the high prevalence of cardiovascular diseases, increasing numbers of complex surgeries, and surgical technology upgrades. Aging populations and rising chronic heart disease prevalence have led to growing demand for high-complexity cardiac and major vascular surgeries, providing a stable market foundation. Double roller pump designs offer superior hemodynamic control, oxygenation efficiency, and adaptability for prolonged surgeries compared to single-pump systems, giving them clear advantages in high-risk procedures and specialized cardiac centers. Additionally, the adoption of minimally invasive surgery and precision perioperative management has raised healthcare providers’ expectations for device performance, precise control, and safety, driving continuous technological innovation and product upgrades. Advances in intelligent control, integrated modules, and remote monitoring have also created new growth opportunities, enhancing the device’s applicability across global healthcare institutions.

Despite technological and clinical advantages, challenges remain. Device and disposable consumable costs are high, constraining adoption in budget-limited hospitals. Operation is complex, requiring trained and experienced staff; improper use may compromise surgical safety. Limitations in hemodynamic control during extremely complex or emergency procedures introduce clinical risks. Differences in performance, modularity, after-sales service, and maintenance convenience across brands can influence hospital purchasing decisions and market competition. Furthermore, long upgrade cycles and inconsistent technology iteration and standardization may affect market expansion speed.

With the expansion of cardiac surgery and an increase in complex procedures, demand for double roller pump artificial heart lung machines continues to grow. High-risk patients, heart transplants, and major vascular surgeries have heightened requirements for precise blood flow control and oxygenation efficiency. The development of minimally invasive and enhanced recovery surgeries imposes higher demands on modular design, intelligent monitoring, and data integration. In the future, double roller pump machines are expected to integrate deeply with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time intraoperative data support and enabling more precise and efficient perioperative management.

The upstream industry for double roller pump artificial heart lung machines primarily includes high-precision dual roller pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. The dual roller pumps and motor modules are the core components, directly determining circulation stability and flow accuracy. Oxygenator and heat exchanger materials require high blood compatibility, oxygenation efficiency, and temperature control precision, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advancements in microelectronic control and advanced medical materials, upstream innovations will continue to enhance performance, safety, and intelligence, supporting device differentiation and market expansion.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Double Roller Pump Artificial Heart Lung Machine market?

What factors are driving Double Roller Pump Artificial Heart Lung Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Double Roller Pump Artificial Heart Lung Machine market opportunities vary by end market size?

How does Double Roller Pump Artificial Heart Lung Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Double Roller Pump Artificial Heart Lung Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Manual Control
• Automatic Control

Segment by Application

• Cardiac Surgery
• Lung Transplant Operation
• Acute Respiratory Failure Treatment
• Others

Segment by Application

• General Hospitals
• Surgical Centers
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Double Roller Pump Artificial Heart Lung Machine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in General Hospitals, Surgical Centers, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact